Select Bibliography

 Search for any words:
Excel csv Word PDF RIS
  Filter by any of these (after searching):
      
Year
      
PubType
      
Endpoint
      
Analysis
      
Datasharing
Neuro-Onc
Committee
      
Program
      
Meeting
      
Funding
                            

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 84 items

Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.    QxMD    Google Scholar
,  ,  ,  ,  ... -    -  J Neurooncol   -  2011    
Manuscript -  Secondary-not-in-original -  Comprehensive -  Neuro-Onc -  Comprehensive ,  NCCTG-85-72-51 ,  NCCTG-86-03-51 ,  NCCTG-88-72-02 ,  NCCTG-88-72-52 ,  NCCTG-90-72-01 ,  NCCTG-91-72-01 ,  NCCTG-92-72-03 ,  NCCTG-93-72-02 ,  NCCTG-93-72-52 ,  NCCTG-88-72-51 ,  NCCTG-89-72-51 ,  NCCTG-89-72-52 ,  NCCTG-91-72-51 ,  NCCTG-92-72-51 ,  NCCTG-93-72-51 ,  NCCTG-95-72-53 ,  NCCTG-98-72-54 ,  NCCTG-N997B ,  NCCTG-84-72-51 ,  NCCTG-86-72-02 ,  NCCTG-86-72-53 ,  NCCTG-N0074 ,  NCCTG-N0272 ,  NCCTG-98-72-52 ,  NCCTG-86-72-51 ,  NCCTG-98-72-51 ,  NCCTG-96-72-51
Improved outcome in recurrent glioblastoma (RGBM) patients treated with bevacizumab (BEV) and sorafenib (SOR) is predicted by a greater drop in apparent diffusion coefficient (ADC) on MRI imaging. Google Scholar
,  ,  ,  ... -  SNO   -  16th Annual Scientific Meeting of the Society for Neuro-Oncology in Conjunction with the AANS/CNS Section on Tumors   -  2011    
Abstract -  Secondary-not-in-original -  Primary -  Neuro-Onc -  NCCTG-N0776


Copyright ©2013 - 2023 Alliance Foundation. All rights reserved.